$SLDB insider trading
Over the last 12 months, Solid Biosciences insiders reported no purchases and 29 sales totaling $2.7M across SEC Form 4 filings. 90% of those filings were made under pre-arranged 10b5-1 trading plans.
- Bought · 12m
- — 0 events
- Sold · 12m
- $2.7M 29 events
- Events · 12m
- 29 Form 4 filings, grouped
- Insiders · 12m
- 7 distinct reporters
- 10b5-1 share
- 90% of events, not dollars
All insider trades
Scroll the table sideways for price, value and marks.
| Date | Insider | Type | Shares | Avg price | Value | Δ stake | Marks |
|---|---|---|---|---|---|---|---|
| Feb 18, 2026 | Cumbo AlexanderPresident and CEO · O·D | ▼ Sale | 16,644 | $5.82 | $97K | -6.6% | plan |
| Feb 18, 2026 | Hanrahan JessieChief Regulatory Officer · O | ▼ Sale | 4,134 | $5.82 | $24K | -5.3% | plan |
| Feb 18, 2026 | Ganot IlanD | ▼ Sale | 2,658 | $5.82 | $15K | -8.8% | plan · indirect |
| Feb 18, 2026 | Herzich PaulChief Technology Officer · O | ▼ Sale | 3,616 | $5.82 | $21K | -4.7% | plan |
| Feb 18, 2026 | Howton David TChief Operating Officer · O | ▼ Sale | 7,469 | $5.82 | $43K | -6.6% | plan |
| Feb 18, 2026 | Brooks GabrielChief Medical Officer · O | ▼ Sale | 0 | — | — | — | plan |
| Feb 18, 2026 | Tan KevinCFO & Treasurer · O | ▼ Sale | 5,404 | $5.82 | $31K | -5.2% | plan |
| Feb 4, 2026 | Howton David TChief Operating Officer · O | ▼ Sale | 18,894 | $6.44 | $122K | -16.2% | plan |
| Feb 4, 2026 | Cumbo AlexanderPresident and CEO · O·D | ▼ Sale | 48,913 | $6.44 | $315K | -18.1% | plan |
| Feb 4, 2026 | Ganot IlanD | ▼ Sale | 7,205 | $6.44 | $46K | -22.2% | plan · indirect |
| Feb 4, 2026 | Tan KevinCFO & Treasurer · O | ▼ Sale | 14,783 | $6.44 | $95K | -13.6% | plan |
| Feb 4, 2026 | Brooks GabrielChief Medical Officer · O | ▼ Sale | 12,616 | $6.44 | $81K | -13% | plan |
| Feb 4, 2026 | Hanrahan JessieChief Regulatory Officer · O | ▼ Sale | 12,348 | $6.44 | $80K | -14.9% | plan |
| Feb 4, 2026 | Herzich PaulChief Technology Officer · O | ▼ Sale | 10,905 | $6.44 | $70K | -13.6% | plan |
| Feb 2, 2026 | Tan KevinCFO & Treasurer · O | ▼ Sale | 26,837 | $6.44 | $173K | -19.8% | plan |
| Feb 2, 2026 | Cumbo AlexanderPresident and CEO · O·D | ▼ Sale | 80,258 | $6.44 | $517K | -22.9% | plan |
| Feb 2, 2026 | Hanrahan JessieChief Regulatory Officer · O | ▼ Sale | 26,535 | $6.44 | $171K | -24.3% | plan |
| Feb 2, 2026 | Brooks GabrielChief Medical Officer · O | ▼ Sale | 28,335 | $6.44 | $182K | -22.7% | plan |
| Feb 2, 2026 | Howton David TChief Operating Officer · O | ▼ Sale | 37,771 | $6.44 | $243K | -24.4% | plan |
| Feb 2, 2026 | Herzich PaulChief Technology Officer · O | ▼ Sale | 26,250 | $6.44 | $169K | -24.7% | plan |
| Jan 28, 2026 | Ganot IlanD | ▼ Sale | 191 | $6.59 | $1K | -1.1% | plan · indirect |
| Jan 13, 2026 | Tan KevinCFO & Treasurer · O | ▼ Sale | 5,704 | $5.27 | $30K | -11% | plan |
| Jan 5, 2026 | Ganot IlanD | ▼ Sale | 1,053 | $5.43 | $6K | -5.7% | indirect |
| Dec 3, 2025 | Howton David TChief Operating Officer · O | ▼ Sale | 4,932 | $5.11 | $25K | -13% | plan |
| Dec 3, 2025 | Cumbo AlexanderPresident and CEO · O·D | ▼ Sale | 10,808 | $5.11 | $55K | -11.7% | plan |
| Dec 3, 2025 | Hanrahan JessieChief Regulatory Officer · O | ▼ Sale | 4,483 | $5.11 | $23K | -14.4% | plan |
| Dec 3, 2025 | Herzich PaulChief Technology Officer · O | ▼ Sale | 2,701 | $5.11 | $14K | -9.2% | plan |
| Nov 10, 2025 | Ganot IlanD | ▼ Sale | 3,278 | $4.12 | $14K | -3.3% | — |
| Oct 20, 2025 | Brooks GabrielChief Medical Officer · O | ▼ Sale | 2,895 | $5.96 | $17K | -7.9% | — |
Every $SLDB filing on this page is one API call away
The same Form 4 data over REST or MCP, already grouped into events with the plan flag and the dollar value read. A free key does 100 calls a day and needs no card. Prefer email? Solid Biosciences filings can reach your inbox instead.
Corporate insiders — officers, directors and 10%+ owners — must report their trades to the SEC on Form 4 within two business days. This page shows open-market activity: purchases (code P), sales (S) and dispositions back to the issuer (D). Scheduled compensation events such as stock grants and option exercises are also filed on Form 4 but carry no trading signal, so they are not shown and counts here can be lower than the raw EDGAR filing total. We group each filing's transactions into one economic event (a laddered 10b5-1 sale is one event, not 25 rows), flag pre-arranged plans and late filings, and link every event to its AI-scored article in the $SLDB feed.